nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adipose Tissue-Liver Cross Talk in the Control of Whole-Body Metabolism: Implications in Nonalcoholic Fatty Liver Disease
|
Azzu, Vian |
|
|
158 |
7 |
p. 1899-1912 |
artikel |
2 |
Circadian Rhythms in the Pathogenesis and Treatment of Fatty Liver Disease
|
Saran, Anand R. |
|
|
158 |
7 |
p. 1948-1966.e1 |
artikel |
3 |
Cover 1
|
|
|
|
158 |
7 |
p. OFC |
artikel |
4 |
Editorial Board
|
|
|
|
158 |
7 |
p. A3-A5 |
artikel |
5 |
Elsewhere in The AGA Journals
|
|
|
|
158 |
7 |
p. A9-A10 |
artikel |
6 |
Information for Authors and Readers
|
|
|
|
158 |
7 |
p. A13-A14 |
artikel |
7 |
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease
|
Eslam, Mohammed |
|
|
158 |
7 |
p. 1999-2014.e1 |
artikel |
8 |
Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis
|
Schwabe, Robert F. |
|
|
158 |
7 |
p. 1913-1928 |
artikel |
9 |
Metabolic Inflammation—A Role for Hepatic Inflammatory Pathways as Drivers of Comorbidities in Nonalcoholic Fatty Liver Disease?
|
Gehrke, Nadine |
|
|
158 |
7 |
p. 1929-1947.e6 |
artikel |
10 |
Nonalcoholic Fatty Liver Disease in 2020
|
Maher, Jacquelyn J. |
|
|
158 |
7 |
p. 1849-1850 |
artikel |
11 |
Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and Challenges
|
Goldner, Dana |
|
|
158 |
7 |
p. 1967-1983.e1 |
artikel |
12 |
Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?
|
Aron-Wisnewsky, Judith |
|
|
158 |
7 |
p. 1881-1898 |
artikel |
13 |
Nonalcoholic Fatty Liver Disease 2020: The State of the Disease
|
Cotter, Thomas G. |
|
|
158 |
7 |
p. 1851-1864 |
artikel |
14 |
Table of Contents
|
|
|
|
158 |
7 |
p. A7-A8 |
artikel |
15 |
Therapeutic Landscape for NAFLD in 2020
|
Neuschwander-Tetri, Brent A. |
|
|
158 |
7 |
p. 1984-1998.e3 |
artikel |
16 |
Toward Genetic Prediction of Nonalcoholic Fatty Liver Disease Trajectories: PNPLA3 and Beyond
|
Krawczyk, Marcin |
|
|
158 |
7 |
p. 1865-1880.e1 |
artikel |